Cargando…

Posaconazole-associated severe hyperbilirubinemia in acute myeloid leukemia following chemotherapy: A case report

BACKGROUND: Posaconazole is a widely used azole antifungal agent, and posaconazole-associated severe hyperbilirubinemia is usually rare in clinical practice. We herein report a 58-year-old male with acute myeloid leukemia, who developed fungal infection following chemotherapy. CASE SUMMARY: After ad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Zai-Wei, Pan, Yu-Chen, Huang, Zhen-Cheng, Liu, Wen-Xi, Zhao, Rong-Sheng, Jing, Hong-Mei, Dong, Fei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306636/ https://www.ncbi.nlm.nih.gov/pubmed/30613684 http://dx.doi.org/10.12998/wjcc.v6.i16.1206

Ejemplares similares

Pharmacokinetics of Venetoclax Co-Administered with Posaconazole in Patients with Acute Myeloid Leukemia
por: De Gregori, Simona, et al.
Publicado: (2023)

Antifungal prophylaxis and novel drugs in acute myeloid leukemia: the midostaurin and posaconazole dilemma
por: Stemler, Jannik, et al.
Publicado: (2020)

ODP442 Posaconazole-induced Pseudohyperaldosteronism (PIPH) in Patient Treated for Acute Myeloid Leukemia
por: Shrestha, Bishow, et al.
Publicado: (2022)

The Outcome of Antifungal Prophylaxis with Posaconazole in Patients with Acute Myeloid Leukemia: A Single-Center Study
por: Özkocaman, Vildan, et al.
Publicado: (2018)

Economic analysis of oral posaconazole prophylaxis in acute myeloid leukemia during remission induction in Turkey
por: Umit, Elif Gulsum, et al.
Publicado: (2020)

Efficacy of posaconazole prophylaxis in acute myeloid leukemia and myelodysplastic syndrome patients treated with hypomethylating agents
por: Kang, Ka-Won, et al.
Publicado: (2020)

Rhabdomyolysis Following Initiation of Posaconazole Use for Antifungal Prophylaxis in a Patient With Relapsed Acute Myeloid Leukemia: A Case Report
por: Mody, Mayur D., et al.
Publicado: (2017)

Breakthrough invasive aspergillosis and diagnostic accuracy of serum galactomannan enzyme immune assay during acute myeloid leukemia induction chemotherapy with posaconazole prophylaxis
por: Calmettes, Claire, et al.
Publicado: (2018)

Successful Treatment of Pediatric Acute Myeloid Leukemia Presenting with Hyperbilirubinemia Secondary to Myeloid Sarcoma: A Case Report
por: Shash, Hwazen A., et al.
Publicado: (2022)

Posaconazole for the prophylaxis of invasive aspergillosis in acute myeloid leukemia: Is it still useful outside the clinical trial setting?
por: Chen, Tsung-Chih, et al.
Publicado: (2020)

Severe Lenalidomide-Associated Hyperbilirubinemia
por: Gildea, Daniel T, et al.
Publicado: (2023)

Hyperbilirubinemia following lenalidomide administration
por: Azmy, Veronica, et al.
Publicado: (2018)

411. Tolerability of Isavuconazole After Posaconazole Toxicity in Leukemia Patients
por: DiPippo, Adam J, et al.
Publicado: (2018)

Posaconazole for lobomycosis
por: Pasqualotto, Alessandro C., et al.
Publicado: (2021)

Posaconazole-Induced Adrenal Insufficiency in a Case of Chronic Myelomonocytic Leukemia
por: Miller, Ann, et al.
Publicado: (2018)

Pharmacokinetics and Pharmacodynamics of Posaconazole
por: Chen, Lu, et al.
Publicado: (2020)

Posaconazole and midostaurin in patients with FLT3‐mutated acute myeloid leukemia: Pharmacokinetic interactions and clinical facts in a real life study
por: Menna, Pierantonio, et al.
Publicado: (2023)

Severe neonatal hyperbilirubinemia leading to exchange transfusion
por: Alizadeh Taheri, Peymaneh, et al.
Publicado: (2014)

Hyperbilirubinemia as a predictor of severity of acute appendicitis
por: Akai, Masaaki, et al.
Publicado: (2019)

SEVERE HYPERBILIRUBINEMIA ASSOCIATED WITH NOVEL CORONAVIRUS INFECTION
por: Fernandez, Lady Sanchez, et al.
Publicado: (2020)

Severe postoperative hyperbilirubinemia in congenital heart disease
por: Chen, Xiaolan, et al.
Publicado: (2021)

Fatal Breakthrough Mucormycosis in an Acute Myelogenous Leukemia Patient while on Posaconazole Prophylaxis
por: Kang, Seung Hun, et al.
Publicado: (2015)

Neonatal hyperbilirubinemia
por: Ben, Matteo Dal, et al.
Publicado: (2014)

Posaconazole and isavuconazole induced hypomagnesaemia
por: Burston, John, et al.
Publicado: (2018)

High bone marrow ID2 expression predicts poor chemotherapy response and prognosis in acute myeloid leukemia
por: Zhou, Jing-Dong, et al.
Publicado: (2017)

Evaluation of Serum Posaconazole Concentrations in Patients with Hematological Malignancies Receiving Posaconazole Suspension Compared to the Delayed-Release Tablet Formulation
por: Belling, Morgan, et al.
Publicado: (2017)

Comparative study of posaconazole and voriconazole for primary antifungal prophylaxis in patients with pediatric acute leukemia
por: Tu, Songji, et al.
Publicado: (2023)

Hyperbilirubinemia Is a Significant Indicator for the Severity of Acute Appendicitis
por: Hong, Young Ran, et al.
Publicado: (2012)

SUN-578 Severe Hyperbilirubinemia Due to Graves' Thyrotoxicosis
por: Thampi, Rahul, et al.
Publicado: (2019)

Severe Hyperbilirubinemia: A Rare Complication of Lyme Disease
por: Baig, Maarij, et al.
Publicado: (2019)

Colorectal cancer patients with liver metastases and severe hyperbilirubinemia: A consecutive series that explores the benefits and risks of chemotherapy
por: Walia, Tamana, et al.
Publicado: (2008)

Developments in chemotherapy for the treatment of acute myeloid leukemia
por: Drummond, Mark W
Publicado: (2019)

Prolonged Vincristine Toxicity Induced by Concurrent Posaconazole in a Child with T-cell Acute Lymphoblastic Leukemia
por: Alavi, Samin, et al.
Publicado: (2013)

Posaconazole aggravates vincristine-related hypertension in children with acute lymphoblastic leukemia: a case report
por: Lin, Chao, et al.
Publicado: (2020)

Myeloid Sarcoma in an Eyelid That Developed during Chemotherapy for Acute Myeloid Leukemia
por: Kang, Hyera, et al.
Publicado: (2016)

Role of posaconazole in the treatment of oropharyngeal candidiasis
por: Ianas, Voichita, et al.
Publicado: (2010)

Therapeutic Drug Monitoring of Posaconazole: an Update
por: Dekkers, Bart G. J., et al.
Publicado: (2016)

Mineralocorticoid hypertension and hypokalaemia induced by posaconazole
por: Boughton, Charlotte, et al.
Publicado: (2018)

Posaconazole: An Update of Its Clinical Use
por: Leung, Simon, et al.
Publicado: (2015)

Comparison of clinical pharmacology of voriconazole and posaconazole
por: Sienkiewicz, Beata M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_67uoimnhkkcvucls86vkjrh7ff